March 29, 2011Joint Institute for Nuclear Research for CERN COMPASS Experiment to Use Solid-State Photo Detectors
February 10, 2010Prestigious University to use Zecotek's LFS Crystals for Next-Generation PET Program
April 15, 2009Zecotek Establishes Ongoing Relationship with CERN with Initial Order of MAPD photo detectors
March 03, 2009Zecotek Closes Financing and Receives Grant Money from the Gov't of Malaysia and Singapore
December 03, 2007Demonstration of 32 inch 3D Display and Insight Media to Advise with 3D Market Entry
Archive of News Releases
To access a complete listing of Zecotek's news releases click here: ...more
White Paper on Visible Spectrum Tunable Fiber Laser Technology
May 24, 2011
Zecotek Releases White Paper on Visible Spectrum Tunable Fiber Laser Technology
Singapore, May 24, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today released a White Paper on its patent-pending visible spectrum fiber laser technology. The White Paper addresses results from government and industry testing as well as new developments in Zecotek’s fiber laser program which offer additional commercial potential. The paper identifies these new areas and provides detail on performance and testing results.
“The Zecotek fiber laser technology represents a significant breakthrough in extending both the range and utility of lasers used in industrial and medical applications, in particular biomedical instrumentation for confocal microscopy and flow cytometry," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “By extending the range and utility of visible spectrum fiber lasers we can accommodate significant new markets with our laser technologies."
Solid-state lasers have long established themselves as the most common coherent light sources in the instrumentation and research fields, even though other approaches, such as optically pumped semiconductor lasers (OPSL) or directly doubled diode lasers have been introduced, and where older types of laser sources, such as gas lasers, are also still widely used in bio-medical applications. However, with the exception of OPSL, conventional lasers in use are limited to a fixed set of available wavelengths, with a notable gap around the green-yellow range, a range particularly important in biotech and medical uses.
Fiber lasers are now a promising alternative. In addition to being generally more robust and efficient, they have a broad continuous range of output wavelength that can be tailored to specific applications, with the possibility of continuously tuneable laser output within wide spectral ranges.
Zecotek’s unique, patent-pending approach to fiber lasers provides for an attractive performance/cost ratio advantage because they are generally more robust and efficient and have a broad continuous range of output wavelength that can be tailored to specific applications. Zecotek lasers offer a range of parameters, which include higher reliability, provisions for various power levels (0.25–1W) and various wavelengths in the green range (515–560 nm), with a focus on the lines of 540, 550, 560 nm (where the 515–560 nm range is important in medical applications). Other options include continuous tuneability with up to 20-nm, multi-wavelength, broad-band, and narrow-band, as well as single-frequency in the wider visible range. Pulsed operation, wider wavelength tuning, and the expansion of the available wavelength range into the red and blue spectra, are also in development.
The White Paper is available for review on the Zecotek website at http://www.zecotek.com/media/VFL-White-Paper-May-2011.pdf.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact: